Cargando…
ApoCIII enrichment in HDL impairs HDL-mediated cholesterol efflux capacity
Apolipoprotein CIII (apoCIII) has been reported to be tightly associated with triglyceride metabolism and the susceptibility to coronary artery disease (CAD). Besides, apoCIII has also been found to affect the anti-apoptotic effects of HDL. However, the effect of apoCIII on HDL-mediated cholesterol...
Autores principales: | Luo, Mengdie, Liu, Aiying, Wang, Shuai, Wang, Tianle, Hu, Die, Wu, Sha, Peng, Daoquan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5443776/ https://www.ncbi.nlm.nih.gov/pubmed/28539597 http://dx.doi.org/10.1038/s41598-017-02601-7 |
Ejemplares similares
-
The association of HDL-apoCIII with coronary heart disease and the effect of statin treatment on it
por: Xiong, Xiaowei, et al.
Publicado: (2015) -
Identification of the HDL-ApoCIII to VLDL-ApoCIII ratio as a predictor of coronary artery disease in the general population: The Chin-Shan Community Cardiovascular Cohort (CCCC) study in Taiwan
por: Chang, Po-Yuan, et al.
Publicado: (2012) -
The negative effect of ANGPTL8 on HDL-mediated cholesterol efflux capacity
por: Luo, Mengdie, et al.
Publicado: (2018) -
Is apoCIII-Lowering A Double-Edged Sword?
por: Tang, Xiangming, et al.
Publicado: (2022) -
Effects of Fructose or Glucose on Circulating ApoCIII and Triglyceride and Cholesterol Content of Lipoprotein Subfractions in Humans
por: Hieronimus, Bettina, et al.
Publicado: (2019)